IgG4相关性疾病3例特征及文献复习(4)
Radiology，2009，251(1)：260-270.
[7]Campbell SN，Rubio E，Loschner AL.Clinical review of pulmonary manifestations of IgG4-related disease[J].Ann Am Thorac Soc，2014，11(9)：1466-1475.
[8]Saeki T，Nishi S，Imai N，et al.Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis[J].Kidney Int，2010，78(10)：1016-1023.
[9]Mizushima I，Yamada K，Fujii H，et al.Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis[J].Mod Rheumatol，2012，22(6)：859-870.
[10]Cortazar FB，Stone JH.IgG4-related disease and the kidney[J].Nat Rev Nephrol，2015，11(10)：599-609.
[11]Kawano M，Saeki T.IgG4-related kidney disease-an update[J].Curr Opin Nephrol Hypertens，2015，24(2)：193-201.
[12]Grados A，Ebbo M，Jean E，et al.IgG4-related disease treatment in 2014：Update and literature review[J].Rev Med Interne，2015，36(6)：395-404.
[13]Yamamoto M，Awakawa T，Takahashi H.Is rituximab effective for IgG4-related disease in the long term？ Experience of cases treated with rituximab for 4 years[J].Ann Rheum Dis，2015，74(8)：e46.
[14]楊彩红，李雪，吴恒莲，等.肾上腺皮质激素助减剂治疗IgG4相关性疾病一例[J].新医学，2014，45(9)：632-635.
收稿日期：2016-07-14；修回日期：2016-08-21 (武加标 任敏 赵东宝)
[7]Campbell SN，Rubio E，Loschner AL.Clinical review of pulmonary manifestations of IgG4-related disease[J].Ann Am Thorac Soc，2014，11(9)：1466-1475.
[8]Saeki T，Nishi S，Imai N，et al.Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis[J].Kidney Int，2010，78(10)：1016-1023.
[9]Mizushima I，Yamada K，Fujii H，et al.Clinical and histological changes associated with corticosteroid therapy in IgG4-related tubulointerstitial nephritis[J].Mod Rheumatol，2012，22(6)：859-870.
[10]Cortazar FB，Stone JH.IgG4-related disease and the kidney[J].Nat Rev Nephrol，2015，11(10)：599-609.
[11]Kawano M，Saeki T.IgG4-related kidney disease-an update[J].Curr Opin Nephrol Hypertens，2015，24(2)：193-201.
[12]Grados A，Ebbo M，Jean E，et al.IgG4-related disease treatment in 2014：Update and literature review[J].Rev Med Interne，2015，36(6)：395-404.
[13]Yamamoto M，Awakawa T，Takahashi H.Is rituximab effective for IgG4-related disease in the long term？ Experience of cases treated with rituximab for 4 years[J].Ann Rheum Dis，2015，74(8)：e46.
[14]楊彩红，李雪，吴恒莲，等.肾上腺皮质激素助减剂治疗IgG4相关性疾病一例[J].新医学，2014，45(9)：632-635.
收稿日期：2016-07-14；修回日期：2016-08-21 (武加标 任敏 赵东宝)